Skip to main content

Hematologic Clinical Trials

What is the purpose of this study?

The purpose of this study is to compare the usual treatment for acute myeloid leukemia (AML) with two different combinations of treatment.

This trial is part of a larger platform study called myeloMATCH > Find out more.

Read More

What is the purpose of this study?

The purpose of this study is to find out if addition of a new oral drug to the usual treatment will lower the chance of your primary central nervous system lymphoma (PCNSL) growing or spreading.

 

Read More

esting for Biomarkers to Match People with Myeloid Cancer to myeloMATCH Clinical Trials for Treatment

What is the purpose of this study?

This trial is the first step in joining a large research study called myeloMATCH.

Read More

What is the purpose of this study?

The purpose of this study is to see the effects on you and your lymphoma of a new drug combination compared to other drugs that are currently used in standard treatment.

Read More

What is the purpose of this study?

One of the treatments for multiple myeloma is with three medicines, all continued indefinitely until they stop working, or side effects happen. Two are tablets, and the third is an injection. In this study, we are testing if the injection can be stopped after around 18 months of treatment with no change to how your multiple myeloma is being controlled.

Read More

What is the purpose of this study?

The purpose of this study is to compare the usual treatment for your Hodgkin lymphoma, which is a standard combination of four drugs, versus the standard combination with one drug of the combination replaced with a new drug that we hope will be more effective and cause you fewer side effects.

Read More

What is the purpose of this study?

The purpose of this trial is to find out if people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) will live longer and have a better quality of life if they start treatment earlier. Some people do not have major symptoms when they are diagnosed with CLL or SLL. Treatment is often started when they show symptoms such as fever, anemia, or night sweats. Studies have shown that early treatment using older chemotherapy drugs doesn’t improve outcomes compared to later treatment.

Read More